Drugs / Espidone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02653729 Background | Sep 2015 → Jan 2016 | psychotic disorder | Aisha Andleeb | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Espidone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02653729 ↗ |
| Route | Oral | “Espidone tablet 2 mg and Donu 10 mg by mouth twice a day” NCT02653729 ↗ |